Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel

European Journal of Pharmacology

Volumn 330, Issue 1, 1997, Pages 15-25

  Galeotti, Nicoletta ^a   Ghelardini, Carla ^a   Capaccioli, Sergio ^a   Quattrone, Alessandro ^a   Nicolin, Angelo ^b   Bartolini, Alessandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

(Mouse); Amitriptyline; Analgesia; Antinociception; Antisense oligonucleotide; Clomipramine; K+ channel; mKv1.1; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; ANTISENSE OLIGONUCLEOTIDE; CLOMIPRAMINE; PERTUSSIS TOXIN; POTASSIUM CHANNEL; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; HOT PLATE TEST; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS DRUG ADMINISTRATION;

AMITRIPTYLINE; ANIMALS; BRAIN CHEMISTRY; CLOMIPRAMINE; MALE; MICE; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; OLIGONUCLEOTIDES, ANTISENSE; PAIN MEASUREMENT; PAIN THRESHOLD; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS; RNA, MESSENGER; SEQUENCE HOMOLOGY; VIRULENCE FACTORS, BORDETELLA;

EID: 0030738279     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)10134-0     Document Type: Article

References (56)

1. Acton, J., McKenna, J.E., Melzack, R., 1992. Amitriptyline produces analgesia in the formalin pain test. Exp. Neurol. 117, 94-96.
2. + channel gene expression in the CNS of the mouse. Soc. Neurosci. Abstr. 17, 1279.
3. Baumann, A., Grupe, A., Ackermann, A., Pongs, O., 1988. Structure of the voltage dependent potassium channel is highly conserved from Drosophila to vertebrate central nervous system. EMBO J. 7, 2457-2463.
4. Besson, J., Chaouch, A., 1987. Peripheral and spinal mechanisms of nociception. Pharmacol. Rev. 67, 67-185.
5. Blagosklonny, M.V., Neckers, L.M., 1994. Oligonucleotides protect cells from the cytotoxicity of several anti-cancer chemotherapeutic drugs. Anti-Cancer Drugs 5, 437-442.
6. Bobker, D.H., Williams, J.T., 1990. Ion conductance affected by 5-HT receptor subtypes in mammalian neurones. Trends Neurosci. 13, 169-173.
7. Bosma, M.M., Allen, M.L., Martin, T.M., Tempel, B.L., 1993. PKA-dependent regulation of mKv1.1, a mouse Shaker-like potassium channel gene, when expressed in CHO cells. J. Neurosci. 13, 5240-5242.
8. Brown, A.M., Birnbaumer, L., 1990. Ionic channels and their regulation by G protein subunits. Annu. Rev. Physiol. 52, 197-213.
9. Brown, D.A., 1990. G-proteins and potassium currents in neurones. Annu. Rev. Physiol. 52, 215-242.
10. Capaccioli, S., Di Pasquale, G., Mini, E., Mazzei, T., Quattrone, A., 1993. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem. Biophys. Res. Commun. 107, 818-825.
11. Catterall, W.A., 1988. Structure and function of voltage-sensitive ion channels. Science 242, 50-61.
12. Chandy, K.G., 1991. Simplified gene nomenclature. Nature 352, 26.
13. Chandy, K.G., Williams, C.B., Spencer, R.H., Aguilar, B.A., Ghanshani, S., Tempel, B.L., Gutman, G.A., 1990. A family of three mouse potassium channel genes with intronless coding regions. Science 247, 973-975.
14. Chen, X.-H., Adams, J.U., Geller, E.B., DeRiel, J.K., Adler, M.W., Liu-Chen, L.-Y., 1995. An antisense oligodeoxynucleotide to μ-opioid receptors inhibits μ-opioid receptor agonist-induced analgesia in rats. Eur. J. Pharmacol. 275, 105-108.
15. Chien, C.-C., Brown, G., Pan, Y.-X., Pasternak, G.W., 1994. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a κ-opioid receptor. Eur. J. Pharmacol. 253, R7-R8.
16. Chung, S., Saal, D.B., Kaczmarek, L.K., 1995. Elimination of potassium channel expression by antisense oligonucleotides in a pituitary cell line. Proc. Natl. Acad. Sci. USA 92, 5955-5959.
17. Deal, K.K., Lovinger, D.M., Tamkun, M.M., 1994. The brain Kv1.1 potassium channel: In vitro and in vivo studies on subunit assembley and posttranslational processing. J. Neurosci. 14, 1666-1676.
18. Galeotti, N., Ghelardini, C., Bartolini, A., 1995. Involvement of the serotoninergic system in the analgesic effect of tricyclic antidepressants. Behav. Pharmacol. 6 (Suppl. 1), 20-21.
19. Galeotti, N., Ghelardini, C., Bartolini, A., 1996. Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. Eur. J. Pharmacol. 308, 125-133.
20. Gao, W.-Y., Han, R-S., Storm, C., Egan, W., Chen, Y.-C., 1992 . Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Mol. Pharmacol. 41, 223-229.
21. + current by isoprenaline in bull-frog atrial myocytes. J. Physiol. (London) 415, 233-249.
22. Goldstein, F.J., Malseed, R.J., Nutz, J.F., 1990. Effect of chronic clomipramine on central DADLE antinociception. Pain 42, 331-336.
23. Goodchild, J., 1989. Inhibition of gene expression by oligonucleotides. In: Cohen, J. (Ed.), Oligodeoxynucleotides, Antisense Inhibitors of Gene Expression. Macmillan, London, pp. 53-77.
24. Haley, T.J., McCormick, G.L., 1957. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12, 12-15.
25. Hepler, J.R., Gilman, A.G., 1992. G proteins. Trends Biochem. Sci. 17, 383-387.
26. Hille, B., 1994. Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci. 17, 531-536.
27. Holz, G.G., Rane, S.G., Dunlap, K., 1986. GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 319, 670-672.
28. Hopkins, W.F., Tempel, B.L., 1992. Members of a mouse subfamily of genes encoding voltage-gated potassium channel subunits form heteromultimers when co-expressed in Xenopus oocytes. Soc. Neurosci. Abstr. 18, 1093.
29. Jan, L.Y., Jan, Y.N., 1989. Voltage-sensitive ion channels. Cell 56, 13-25.
30. Lucas, J.J., Hen, R., 1995. New players in the 5-HT receptor field: genes and knockout. Trends Pharmacol. Sci. 16, 246-252.
31. Murua, V.S., Molina, V.A., 1991. Chronic antidepressant counteracts the conditioned analgesia induced by a context previously associated with inescapable shock. Psychopharmacology 105, 439-441.
32. O'Callaghan, J.P., Holtzman, S.G., 1975. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J. Pharmacol. Exp. Ther. 192, 497-505.
33. Pazos, A., Palacios, J.M., 1985. Quantitative autoradiographic mapping of serotonin receptors in the rat brain I. Serotonin-1 receptors. Brain Res. 346, 205-230.
34. Quattrone, A., Papucci, L., Schiavone, N., Mini, E., Capaccioli, S., 1994. Intracellular enhancement of intact antisense oligonucleotide steadystate levels by cationic lipids. Anti-Cancer Drug Design 9, 549-553.
35. Quattrone, A., Fibbi, G., Pucci, M., Anichini, E., Capaccioli, S., Del Rosso, M., 1995a. Reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibiting the urokinase receptor gene expression. Cancer Res. 55, 91-95.
36. Quattrone, A., Papucci, L., Santini, V., Schiavone, N., Noferini, D., Calastretti, A., Copreni, E., Morelli, S., Rossi Ferrini, P.L., Nicolin, A., Capaccioli, S., 1995b. Quantitation of bcl-2 oncogene expression in cultured follicular lymphoma and primary leukemia B-cells by a highly sensitive RT-PCR method. Haematologica 80, 495-504.
37. Robertson, B., Owen, D.G., 1993. Pharmacology of a cloned potassium channel from mouse brain (MK-1) expressed in CHO cells: effects of blockers and an 'inactivation peptide'. Br. J. Pharmacol. 109, 725-735.
38. Rossi, G., Pan, Y.X., Cheng, J., Pasternak, G.W., 1994. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor. Life Sci. 54, PL375-PL379.
39. Sacerdote, P., Brini, A., Mantegazza, P., Panerai, A.E., 1987. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol. Biochem. Behav. 26, 153-158.
40. + channels conserved in flies, mice and humans. Trends Neurosci. 15, 161-166.
41. Schick, B.P., Eras, J.L., Mintz, P.L., 1995. Phosphorothioate oligonucleotides cause degradation of secretory but not intracellular serglycin proteoglycan core protein in a sequence-independent manner in human megacaryocytic tumor cells. Antisense Res. Dev. 5, 59-65.
42. + current in human T lymphocytes. J. Membr. Biol. 117, 263-274.
43. Standifer, K.M., Chien, C.C., Wahlestedt, C., Brown, G.P., Pasternak, G.W., 1994. Selective loss of 5 opioid analgesia and binding by antisense oligodeoxynucleotides to a 5 opioid receptor. Neuron 12, 805-810.
44. Standifer, K.M., Jenab, S., Su, W., Chien, C.-C., Pan, Y.-X., Inturrisi, C.E., Pasternak, G.W., 1995. Antisense oligodeoxynucleotides to the cloned δ receptor DOR-1: uptake, stability, and regulation of gene expression. J. Neurochem. 65, 1981-1987.
45. Stein, C.A., Cheng, Y.-C., 1993. Antisense oligonucleotides as therapeutic agents - Is the bullet really magic?. Science 261, 1004-1011.
46. Storey, A., Oates, D., Banks, L., Crawford, L., Crook, T., 1991. Antisense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Nucleic Acids Res. 19, 4109-4114.
47. Tempel, B.L., Jan, Y.N., Yan, L.Y., 1988. Cloning of a probable potassium channel gene from the mouse brain. Nature 332, 837-839.
48. Tseng, L.F., Collins, K.A., 1994. Antisense oligodeoxynucleotide to a δ-opioid receptor given intrathecally blocks i.c.v. administered β-endorphin-induced antinociception in the mouse. Life Sci. 55, PL127-PL131.
49. Tseng, L.F., Collins, K.A., Kampine, J.P., 1994. Antisense oligodeoxynucleotide to a δ-opioid receptor selectively blocks the spinal antinociception induced by δ-, but not by μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258, R1-R4.
50. Vaught, J., Pelley, K., Costa, L.G., Sether, P., Enna, S.J., 1985. A comparison of the antinociceptive responses to GABA-receptor agonists THIP and baclofen. Neuropharmacology 24, 211-216.
51. Wahlestedt, C., 1994. Antisense oligonucleotide strategies in neurophar-macology. Trends Pharmacol. Sci. 15, 42-46.
52. + channels in terminal and juxtaparanodal regions of neurons. Nature 365, 75-79.
53. Wang, H., Kunkel, D.D., Schwartzkroin, P.A., Tempel, B.L., 1994. Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J. Neurosci. 14, 4588-4599.
54. Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J., Neckers, L.M., 1993. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: Implications for therapeutic application within the central nervous system. Proc. Natl. Acad. Sci. USA 90, 4665-4669.
55. 1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 271, 1462-1470.
56. Zifa, E., Pillion, G., 1992. 5-hydroxytryptamine receptors. Pharmacol. Rev. 44, 401-458.